金融界2025年7月12日消息，国家知识产权局信息显示，铜陵贝斯美科技有限公司申请一项名为"一种2- 戊醇脱氢生产2-戊酮的工艺方法"的专利，公开号CN120289284A，申请日期为2025年03月。 专利摘要显示，本发明属于精细化工技术领域，具体涉及一种2‑戊醇脱氢生产2‑戊酮的工艺方法。本发 明以2‑戊醇为原料，采用上进下出的进料方式，将2‑戊醇送入脱氢反应器，在催化剂和助剂的作用下进 行脱氢反应；本发明的催化剂通过硼磷的协同作用，结合分级孔载体与Fe电子调控，降低反应能，促进 脱氢反应的进行，提高2‑戊酮的纯度，解决了其因结焦而逐渐丧失活性的问题，使用寿命长。将其和助 剂共同加入反应体系中，相互协同，助剂能够促进2‑戊醇的脱氢反应，抑制副反应的发生，进而提高产 物的得率和纯度。然后将2‑戊醇反应液通过连续精馏进行，在脱轻塔对轻组分进行脱除，脱重塔塔顶得 到高纯度2‑戊酮，使得2‑戊醇脱氢效率显著提高，同时极大地降低生产能耗成本。 天眼查资料显示，铜陵贝斯美科技有限公司，成立于2020年，位于铜陵市，是一家以从事化学原料和化 学制品制造业为主的企业。企业注册资本29677.9141万人民币。通过天眼查大 ...

【DT新材料】 获悉，近日， 中石 化 迎来二大关键产品技术突破！ 1. 己内酰胺成套技术：打破垄断！ 建成全球最大装置 近日， 中国石油和化学工业联合会 组织鉴定委员会对 石科院 牵头完成 的" 变革性己内酰胺成套技术及产业化应用 "进 行了科技成果鉴定。鉴定委员 会一致认定，此项变革性己内酰胺成套技术整体达到国际领先水平。 己内酰胺 是第二大合成纤维和工程塑料尼龙6的单体，广泛应用于纺织、包装、电子、汽车、航天航空等新材料领域。 然而，其生产长期被高能耗、 高排放、复杂工艺与安全风险所困扰，国内产业更面临三重严峻挑战： 1. 原料生产瓶颈： 环己酮 传统工艺存在碳原子利用率低、三废排放量大等问题，被列入国家重点环境风险防控化学品名单； 2.技术封锁限制： 过氧化氢 生产技术受制于国外封锁， 国内固定床技术生产效率低、重大安全事故频发等问题； 3.产品性能与环保压力：高端领域应用受限，以及生产能耗和二氧化碳排放高，废水排放量大且COD、氨氮、总氮含量高，具有强生物毒性，影响生化 系统运行等问题。 对此，团队国际首创 环己烯酯化加氢制备环己酮新技术 ：发明 负载型苯选择加氢催化剂和工艺，攻克高活性、高选择性不 ...

Core Viewpoint - China Petrochemical Corporation (Sinopec) has achieved a significant breakthrough in the development of a fluidized bed hydrogen peroxide production technology, breaking the long-standing foreign monopoly and providing technological support for the upgrade of domestic hydrogen peroxide production technology [1][3]. Group 1: Technology Development - The newly developed fluidized bed hydrogen peroxide production technology has been in development for 15 years, resulting in 72 Chinese invention patents and 1 PCT international patent [3]. - The technology integrates multiple innovations, including three types of catalysts, three process enhancements, and two new reactions, significantly improving production efficiency and enabling large-scale production [3][4]. Group 2: Market Position and Production Capacity - In 2022, China accounted for over 50% of the global hydrogen peroxide market share, with an annual production capacity of 24 million tons, although the production process primarily relied on outdated fixed bed technology [3]. - The first domestic industrial production unit using Sinopec's fluidized bed technology was established in Hunan in 2018, with a capacity of 72,000 tons per year, outperforming domestic technology standards [4]. Group 3: Future Prospects and Economic Impact - The fluidized bed technology is expected to address essential safety issues in hydrogen peroxide production and has been recognized for its industry promotion value [4]. - In 2024, Hunan Petrochemical is projected to produce a total of 585,000 tons of hydrogen peroxide, with significant reductions in comprehensive energy consumption compared to the previous year [4].

Core Viewpoint - The invention of a new plant oil polyol structure and its manufacturing process has been awarded the Gold Prize at the 25th China Patent Awards, highlighting its potential to innovate the bio-based polyurethane industry and reduce reliance on petrochemical resources [2] Group 1: Innovation and Technology - The project developed an efficient manufacturing process for plant oil polyols, enabling the production of bio-based polyurethane materials at a scale of tens of thousands of tons [2] - The traditional petrochemical-based polyurethane industry faces challenges due to high dependency on imported high-end products and rising costs, which the new bio-based polyols aim to address [2][3] - The team utilized microchemical and process amplification technologies to enhance reaction selectivity and efficiency, allowing for precise construction of desired structures [2][3] Group 2: Market Applications and Impact - The bio-based polyurethane products are expected to fill the market gap for high-performance polyols, which are currently not met by existing products [2] - The technology has led to the establishment of a production line with an annual capacity of 50,000 tons of bio-based polyurethane polyols, covering a total of 150,000 tons of bio-based polyurethane products [3] - These products have diverse applications in tunnel construction, engineering anti-corrosion, building materials adhesives, electronic potting, and healthcare [3]

Core Viewpoint - The transformative caprolactam technology developed by the Sinopec Petroleum and Chemical Research Institute has been recognized as internationally leading, addressing key challenges in the domestic caprolactam industry [1] Group 1: Industry Challenges - Caprolactam is a crucial monomer for nylon 6, widely used in various sectors, but its production is energy-intensive and environmentally harmful [2] - Historically, China relied on imports for caprolactam, leading to significant investments to establish domestic production, which faced high costs and pollution issues [2] - The domestic caprolactam industry faces three major barriers: low carbon atom utilization and high emissions in traditional cyclohexanone production, technological restrictions on hydrogen peroxide, and quality issues in high-end applications [2] Group 2: Technological Innovations - The research team has pioneered a new cyclohexanone production technology that improves carbon atom utilization from 80% to over 95% and reduces waste emissions by 90% [3] - A novel fluidized bed technology for hydrogen peroxide production has been developed, enhancing safety and efficiency [3] - Key technologies have been created to improve the intrinsic quality of caprolactam, enabling it to meet high-speed spinning requirements and reducing CO2 and waste emissions by 43% and 73% respectively [4] Group 3: Collaborative Development - The successful industrialization of the new caprolactam technology is attributed to a collaborative innovation mechanism involving multiple stakeholders, including Sinopec and various research institutions [5] - The new technology has led to the establishment of the world's largest and most advanced caprolactam production facility, achieving significant reductions in CO2 and pollutant emissions, as well as production costs [5] - In 2024, this transformative technology is set to be recognized as one of the 30 major engineering projects by the Chinese Academy of Engineering [5]

金融界 2025 年 6 月 14 日消息，国家知识产权局信息显示，南通立洋化学有限公司;南通醋酸化工股份 有限公司申请一项名为"一种 2-氰基吡啶的纯化方法"的专利，公开号 CN120136782A，申请日期为 2023 年 12 月。 南通醋酸化工股份有限公司，成立于1959年，位于南通市，是一家以从事化学原料和化学制品制造业为 主的企业。企业注册资本20738.1万人民币。通过天眼查大数据分析，南通醋酸化工股份有限公司共对 外投资了15家企业，参与招投标项目13次，财产线索方面有商标信息6条，专利信息173条，此外企业还 拥有行政许可25个。 专利摘要显示，本发明公开了一种 2‑氰基吡啶的纯化方法，属于化工技术领域。本发明 2‑氰基吡啶的 纯化方法包括：在以 2‑甲基吡啶为原料，氨氧催化制备 2‑氰基吡啶粗品过程中，将得到的 2‑氰基吡啶 粗品经过装有金属吸附剂的吸附柱进行吸附除杂，即得到纯品 2‑氰基吡啶；所述金属吸附剂为 Li、 Cs、Be、Rb 中的两种或多种金属与石墨烯复合而成。通过该方法能够将纯度为 99.8％的 2‑氰基吡啶提 纯至 99.99％，得到高品质的 2‑氰基吡啶，同时无需回流回流 ...

【DT新材料】 获悉，6月6日， 中国平煤神马集团 10万吨/年艾斯安装置投产暨20万吨/年艾斯安项目启动仪式在尼龙科技公司举行， 标志着我国尼龙 66关键原材料己二腈长期依赖进口的局面实现重大突破。 其中， 中国平煤神马集团 尼龙科技公司 10万吨/年艾斯安项目一期工程建设规模为5万吨/年氨基己腈， 技术为 通 过己内酰胺氨化脱水直接生产氨基 己腈 ，然后加氢得到己二胺，绕过传统己二腈工艺，降低对进口原料的依赖。 该项目投资额为50294.71万。此前，平煤神马集团已先期建设了2万吨/年艾斯安项目（即 2万吨/年 氨基己腈 ），并于2023年第三季度投料试车，项目 投资额约为2.7亿元。 中国平煤神马集团 尼龙科技公司 是平煤神马集团旗下专注于尼龙化工领域的核心企业，成立于2014年2月，注册资本68.8亿元，总部位于河南省平顶 山市尼龙新材料产业集聚区，承担煤基尼龙产业链关键原料的研发与生产。公司 目标在 " 十 四五 " 期间 实现 40万吨/年己内 酰胺 、 15万吨/年己二 酸、45万吨尼龙 6切片( 含永通公司 ）一体化产业布局，在 "十五五"前期实现 60万吨/年己内酰胺产能。 尼龙科技公司 旗 ...

Core Viewpoint - The third National Postdoctoral Innovation and Entrepreneurship Competition has launched a "Challenge and Lead" project list, featuring 766 technology projects that seek participation from postdoctoral researchers and teams [1][2]. Group 1: Competition Overview - The competition is the largest and most comprehensive postdoctoral event in China, aimed at promoting the integration of industry, academia, and research [1]. - The "Challenge and Lead" segment invites enterprises to present technical challenges, which postdoctoral researchers are encouraged to solve [1]. Group 2: Project Details - A total of 766 project demands have been released, focusing on four key areas aligned with national strategies and cutting-edge scientific technologies, with a total planned investment exceeding 40 billion yuan [2]. - The projects cover seven major directions, including new generation information technology and artificial intelligence, high-end equipment manufacturing, and robotics [2]. - The top areas of demand include: - New generation information technology and artificial intelligence: 143 projects (18.7%) - Biomedicine and health: 140 projects (18.3%) - New materials and petrochemicals: 135 projects (17.6%) - High-end equipment manufacturing and robotics: 131 projects (17.1%) - New energy and energy conservation: 93 projects (12.1%) - Modern agriculture and food: 67 projects (8.7%) - Other industries: 57 projects (7.4%) [2]. Group 3: Participation and Timeline - The project list has been publicly released on various platforms, including the China Postdoctoral website and the official competition website [3]. - The registration deadline for participation is July 31, 2025, with successful teams invited to the finals in Quanzhou, Fujian Province, in mid to late October [3].

科创板风险提示：本次发行股票拟在科创板上市，科创板公司具有研发 投入大、经营风险高、业绩不稳定、退市风险高等特点,投资者面临较大的市 场风险。投资者应充分了解科创板的投资风险及本公司所披露的风险因素， 审慎作出投资决定。 上海康鹏科技股份有限公司 Shanghai Chemspec Corporation 上海市普陀区祁连山南路 2891 弄 200 号 1 幢 首次公开发行股票并在科创板上市 招股说明书 保荐人（主承销商） （北京市朝阳区安立路 66 号 4 号楼） 上海康鹏科技股份有限公司 招股说明书 发行概况 | 发行股票类型 | 股） 人民币普通股（A | | | | | | --- | --- | --- | --- | --- | --- | | | 本次公开发行股票数量为 | | | | 10,387.50 万股，占发行后总股本的比 | | 发行股数 | 例为 | | | | 20%。本次发行全部为发行新股，不涉及公司股东公开发售 | | | 股份。 | | | | | | 每股面值 | 人民币 元 1.00 | | | | | | 每股发行价格 | 人民币 8.66 | | | 元 | | | ...

证券简称： 瑞华技术 证券代码： 872869 常州瑞华化工工程技术股份有限公司 常州市武进区科教城创研港 1 号 5 楼 常州瑞华化工工程技术股份有限公司招股说明书（申报稿） 本公司的发行申请尚未经中国证监会注册。本招股说明书申报稿不具有据以发行股 票的法律效力，投资者应当以正式公告的招股说明书全文作为投资决定的依据。 本次股票发行后拟在北京证券交易所上市，该市场具有较高的投资风险。北京证券 交易所主要服务创新型中小企业，上市公司具有经营风险高、业绩不稳定、退市风险高 等特点，投资者面临较大的市场风险。投资者应充分了解北京证券交易所市场的投资风 险及本公司所披露的风险因素，审慎作出投资决定。 保荐人（主承销商） 0 （北京市朝阳区安立路 66 号 4 号楼） 中国证监会和北京证券交易所对本次发行所作的任何决定或意见，均不表明其对注册申 请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行人的盈利能力、 投资价值或者对投资者的收益作出实质性判断或者保证。任何与之相反的声明均属虚假不实 陈述。 根据《证券法》的规定，股票依法发行后，发行人经营与收益的变化，由发行人自行负 责；投资者自主判断发行人 ...